S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
All the trading advice you’ve ever received boils down to this (Ad)
Dozens of animals taken from Virginia roadside zoo as part of investigation
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
All the trading advice you’ve ever received boils down to this (Ad)
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
All the trading advice you’ve ever received boils down to this (Ad)
Dozens of animals taken from Virginia roadside zoo as part of investigation
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
All the trading advice you’ve ever received boils down to this (Ad)
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
All the trading advice you’ve ever received boils down to this (Ad)
Dozens of animals taken from Virginia roadside zoo as part of investigation
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
All the trading advice you’ve ever received boils down to this (Ad)
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
All the trading advice you’ve ever received boils down to this (Ad)
Dozens of animals taken from Virginia roadside zoo as part of investigation
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
All the trading advice you’ve ever received boils down to this (Ad)
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa

Check-Cap Stock Price, News & Analysis (NASDAQ:CHEK)

$2.70
-0.02 (-0.74%)
(As of 12/8/2023 ET)
Compare
Today's Range
$2.62
$2.87
50-Day Range
$2.61
$4.07
52-Week Range
$1.22
$5.90
Volume
7,373 shs
Average Volume
15,639 shs
Market Capitalization
$13.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00

Check-Cap MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
159.3% Upside
$7.00 Price Target
Short Interest
Healthy
1.27% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.71mentions of Check-Cap in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.28) to ($0.99) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.19 out of 5 stars

Medical Sector

348th out of 933 stocks

X - Ray Apparatus & Tubes Industry

4th out of 6 stocks


CHEK stock logo

About Check-Cap Stock (NASDAQ:CHEK)

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.

CHEK Stock Price History

CHEK Stock News Headlines

New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
StockNews.com Begins Coverage on Check-Cap (NASDAQ:CHEK)
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Check-Cap GAAP EPS of -$0.44
Check-Cap: Q3 Earnings Insights
Check-Cap Posts Narrower Loss In Q3 - Quick Facts
Check-Cap Ltd CHEK
Notice of Extraordinary General Meeting of Shareholders
Kazakhstan Aims to Cut Loan-Rate Cap
Check-Cap Ltd.
Check-Cap to combine with Keystone Dental Holdings
See More Headlines
Receive CHEK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Check-Cap and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/27/2023
Today
12/10/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
3/29/2024

Industry, Sector and Symbol

Industry
X - ray apparatus & tubes
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CHEK
Employees
85
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$7.00
High Stock Price Target
$7.00
Low Stock Price Target
$7.00
Potential Upside/Downside
+159.3%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$-19,110,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$8.57 per share

Miscellaneous

Free Float
4,798,000
Market Cap
$13.01 million
Optionable
Not Optionable
Beta
0.34
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Alex Ovadia (Age 61)
    CEO & Director
    Comp: $409.35k
  • Dr. Yoav Kimchy Ph.D. (Age 62)
    Founder & Chief Technology Officer
    Comp: $362.65k
  • Ms. Mira Rosenzweig (Age 51)
    Chief Financial Officer
    Comp: $287.99k
  • Mr. Joshua Belkar (Age 54)
    Vice President of Operations
    Comp: $269.57k
  • Ms. Noa Reshef M.B.A.
    Director of Human Resources














CHEK Stock Analysis - Frequently Asked Questions

Should I buy or sell Check-Cap stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Check-Cap in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" CHEK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CHEK, but not buy additional shares or sell existing shares.
View CHEK analyst ratings
or view top-rated stocks.

What is Check-Cap's stock price target for 2024?

1 Wall Street analysts have issued twelve-month price objectives for Check-Cap's stock. Their CHEK share price targets range from $7.00 to $7.00. On average, they expect the company's stock price to reach $7.00 in the next year. This suggests a possible upside of 159.3% from the stock's current price.
View analysts price targets for CHEK
or view top-rated stocks among Wall Street analysts.

How have CHEK shares performed in 2023?

Check-Cap's stock was trading at $2.20 on January 1st, 2023. Since then, CHEK shares have increased by 22.7% and is now trading at $2.70.
View the best growth stocks for 2023 here
.

Are investors shorting Check-Cap?

Check-Cap saw a decline in short interest during the month of November. As of November 15th, there was short interest totaling 66,200 shares, a decline of 23.1% from the October 31st total of 86,100 shares. Based on an average trading volume of 44,400 shares, the days-to-cover ratio is currently 1.5 days. Currently, 1.3% of the shares of the stock are sold short.
View Check-Cap's Short Interest
.

When is Check-Cap's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, March 29th 2024.
View our CHEK earnings forecast
.

How were Check-Cap's earnings last quarter?

Check-Cap Ltd. (NASDAQ:CHEK) released its quarterly earnings results on Monday, November, 27th. The medical research company reported ($0.44) earnings per share for the quarter, beating the consensus estimate of ($0.83) by $0.39.

When did Check-Cap's stock split?

Check-Cap shares reverse split on the morning of Friday, November 25th 2022. The 1-20 reverse split was announced on Friday, November 25th 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, November 25th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Check-Cap own?
When did Check-Cap IPO?

(CHEK) raised $13 million in an IPO on Thursday, February 19th 2015. The company issued 1,200,000 shares at a price of $10.00-$12.00 per share. Chardan Capital Markets and Maxim Group acted as the underwriters for the IPO and Feltl and Company was co-manager.

How do I buy shares of Check-Cap?

Shares of CHEK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:CHEK) was last updated on 12/10/2023 by MarketBeat.com Staff

My Account -